Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

@article{Kannel1979DiabetesAG,
  title={Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study},
  author={W. Kannel and D. McGee},
  journal={Diabetes Care},
  year={1979},
  volume={2},
  pages={120 - 126}
}
This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke… Expand
The relation of insulin resistance syndromes to risk of cardiovascular disease.
  • R. Nesto
  • Medicine
  • Reviews in cardiovascular medicine
  • 2003
TLDR
The relationship between diabetes and the risk of CVD is reviewed, in which insulin resistance and hyperglycemia gradually worsen, and vascular complications develop. Expand
Dyslipidemia in type II Diabetes: Implications for Therapeutic Intervention
TLDR
There is an urgent need for large-scale clinical trials assessing cardiovascular end points and testing various strategies of improving lipid profiles in diabetic subjects, particularly given the fact that all of the current generation of lipid-lowering trials have systematically excluded diabetic patients. Expand
Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.
TLDR
Most CHD preventive measures, including weight control, exercise, avoidance of cigarettes, and improvement of glucose tolerance also increase HDL cholesterol, reduced levels of which are chiefly responsible for the poor LDL/HDL ratio in diabetics. Expand
Is hyperglycemia associated with cardiovascular disease? The Framingham Study.
TLDR
It is shown that hyperglycemia in the original Framingham cohort is an independent risk factor for CVD in nondiabetic women, but not among men. Expand
Adverse Effects of Diabetes on Multiple Cardiovascular Disease Risk Factors in Women: The Strong Heart Study
TLDR
Compared with diabetes-associated differences in men, diabetes in women was related to greater adverse differences in levels of several CVD risk factors, and the combined effects of these risk factor differences in diabetic women may be substantial. Expand
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease
TLDR
The data suggest that beyond LDL-C, a lower creatinine clearance and more subtle alterations of LDL particles, together with a constellation of several well known and emerging cardiovascular risk factors, are stronger contributors to the high CHD risk of diabetic women. Expand
Cardiovascular disease in diabetes, beyond glucose.
TLDR
Evidence consistent with the importance of factors beyond hyperglycemia has emerged and an increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes. Expand
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective.
TLDR
The aim of this review is to discuss the pathophysiological, pharmacological and clinical evidence supporting the appropriate use of low-dose aspirin in DM, within the context of the current multifactorial approach to primary cardiovascular prevention. Expand
The effect of hyperglycemia and its therapies on the heart.
  • K. Wyne
  • Medicine
  • Heart failure clinics
  • 2006
TLDR
The incidence of DM in patients who have heart failure is increased markedly above that of the general population, leading to questions regarding the role of diabetes in the cause of heart failure. Expand
Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
  • S. Zarich
  • Medicine
  • Reviews in cardiovascular medicine
  • 2003
TLDR
Strict glycemic control must, therefore, be accompanied with proven therapies (such as antihypertensives and lipid-lowering agents) to reduce cardiovascular events in patients with type 2 diabetes. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Role of diabetes in congestive heart failure: the Framingham study.
TLDR
The data suggest that diabetes is another discrete cause of congestive heart failure and that some form of cardiomyopathy is associated with diabetes, as a result of either small vessel disease or metabolic disorders. Expand
Diabetes and the heart: coronary heart disease.
  • J. Jarrett
  • Medicine
  • Clinics in endocrinology and metabolism
  • 1977
TLDR
In treating diabetics there is an a priori case for using diets designed to lower plasma lipid levels as well as the blood sugar, for early treatment of hypertension and for discouraging cigarette smoking. Expand
Cardiovascular complications in diabetics.
TLDR
All diabetics manifested a decidedly increased incidence of atherosclerotic cardiovascular disease regardless of the type of treatment followed, and in both sexes, the percent of excess risk was most pronounced for IC. Expand
Predictive Value of Lipoprotein and Cholesterol Determinations in Diabetic Patients who Developed Cardiovascular Complications
A follow-up study was performed on 690 white diabetic patients 2 to 5 years after their blood had been analyzed for lipoprotein and cholesterol to determine if these lipid measures had any predictiveExpand
Some aspects of hypertension in diabetes mellitus.
Several facets of hypertension in diabetes mellitus were studied in 662 employed diabetics and an equal number of matched controls, all of whom received periodic health examinations at work. TheExpand
Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico.
TLDR
The answer is clear that the average Honolulu Japanese and Puerto Rican has a lower CHD incidence than his counterpart in Framingham, and even after allowing for differences in population characteristics, the difference is statistically significant and about 2-1 in magnitude. Expand
Ischemic Heart Disease: Insulin, Carbohydrate, and Lipid Interrelationships
TLDR
Canonical correlations revealed that IRI is the common denominator in both carbohydrate and lipid abnormalities in IHD, and was neither related to relative weight nor to elapsed time from onset of IHD to time of examination. Expand
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease.
TLDR
An increased incidence of both abnormal lipoprotein patterns and abnormal reactions to glucose tolerance tests was found in 134 patients with documented coronary artery disease, and the importance of determining specific metabolic abnormalities is stressed. Expand
PLASMA-LIPIDS AND GLUCOSE/INSULIN RELATIONSHIP IN NON-INSULIN-REQUIRING DIABETICS WITH AND WITHOUT RETINOPATHY
TLDR
It is suggested that insulin deficiency with secondary hyperlipidaemia is characteristic of diabetic patients with retinopathy. Expand
Diabetes mellitus in American (Pima) Indians.
TLDR
The findings indicate that the Pima Indians have the highest prevalence of diabetes mellitus yet recorded, and that in this population normal and hyperglycaemic groups may be logically separated on the basis of the bimodality of the frequency distributions of two-hour post-load glucose levels. Expand
...
1
2
3
4
...